An Omicron-specific, self-amplifying mRNA booster vaccine for COVID-19: a phase 2/3 randomized trial.
Saraf A, Gurjar R, Kaviraj S, Kulkarni A, Kumar D, Kulkarni R, Virkar R, Krishnan J, Yadav A, Baranwal E, Singh A, Raghuwanshi A, Agarwal P, Savergave L, Singh S; GEMCOVAC-OM Study Investigators.
Saraf A, et al.
Nat Med. 2024 Apr 18. doi: 10.1038/s41591-024-02955-2. Online ahead of print.
Nat Med. 2024.
PMID: 38637636